Two Sigma Advisers’s CureVac CVAC Stock Holding History

Two Sigma Advisers’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,400	Closed	-$124K	–	538
2025 Q4	$124K	Buy	+27,400	New	+$140K	﹤0.01%	2194
2025 Q1	–	Sell	-14,200	Closed	-$48.4K	–	2426
2024 Q4	$48.4K	Buy	+14,200	New	+$40.9K	﹤0.01%	2284

Two Sigma Advisers's CVAC Position: Q1 2026 in Review

Two Sigma Advisers sold out of CureVac (CVAC) in Q1 2026, closing a stake of 27,400 shares — an estimated $124K sold.

Two Sigma Advisers first reported a position in CVAC in Q4 2024 and held it in 2 quarters. The position peaked at $124K in Q4 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

Two Sigma Advisers reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 27,400 CureVac shares in Q1 2026, an estimated $124K.
Two Sigma Advisers first reported a position in CureVac in Q4 2024 and held it in 2 quarters.
Two Sigma Advisers's CureVac position peaked at $124K in Q4 2025.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.